(Q67837799)
Statements
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison (English)
Hiddemann W
Aul C
Maschmeyer G
Schönrock-Nabulsi R
Ludwig WD
Bartholomäus A
Bettelheim P
Becker K
Balleisen L
1 July 1991